World's Best BYO No. 10

World's Best BYO No. 10

Celebrating its tenth year, the Fink Group and Cure Cancer Australia once again joined forces to host the World’s Best BYO at OTTO Ristorante at Woolloomooloo’s Finger Wharf.

Table placements at OTTO Ristorante

Table placements at OTTO Ristorante

The popular epicurean event, held on Tuesday 15 August 2017, saw 200 of Sydney’s most generous bon vivants bring along their best bottles, raise their glasses and dig deep to support vital cancer research at the annual ‘World’s Best BYO’. The MC for the evening was the fabulous Kerri-Anne Kennerley, who has herself been touched by cancer.

AN ESTEEMED GUEST LIST

Guests including Glenn and Sarah McGrath, Lyndey Milan, John Fink, Philip Nick Smith, Deborah Hutton, Rob Remnant, Leanne Whitehouse, Charlie Brown and Mandy Foley joined the fun, bringing along their most prized vintages of wine and Champagne to match an extraordinary Italian menu prepared by Executive Chef Richard Ptacnik and at the same time, raising vital funds to support cancer research through Cure Cancer Australia. Guests heard from Cure Cancer Australia's very own CEO Floyd Larsen, Chairman of the Board, Philip Corne and Cure Cancer Australia Ambassador, Lisa Greissl.

OUR SOMMELIERS

Some of Australia’s best sommeliers, hailing from Bennelong, Quay, Otto, Lucio’s, Ivy,  Mercado, Black Bar & Grill, Glass, Upstairs and Tapavino were on hand throughout the night to pour guests’ special vintages into varietal-specific Riedel glassware and to recommend particular wines for each course.

MAGNIFICENT PRIZES RAISE FUNDS

On arrival, guests sipped on Piper Heidsick, and during the evening bid on magnificent prizes from Louis Vuitton, One&Only Resorts, Paspaley, Cloudy Bay, R. M. Williams, Tag Heuer, BVLGARI, Loewe, Fendi, Burberry and The Fink Group, raising over $160,000 to fund new research grants for Cure Cancer Australia.

Over its ten-year history, the event has raised over $1.7 million, allowing us to continue funding some of the brightest innovators in cancer research.

 
 
Loading...